Alternative Polyadenylation Patterns for Novel Gene Discovery and Classification in Cancer

Certain aspects of diagnosis, prognosis, and treatment of cancer patients are still important challenges to be addressed. Therefore, we propose a pipeline to uncover patterns of alternative polyadenylation (APA), a hidden complexity in cancer transcriptomes, to further accelerate efforts to discover novel cancer genes and pathways. Here, we analyzed expression data for 1045 cancer patients and found a significant shift in usage of poly(A) signals in common tumor types (breast, colon, lung, prostate, gastric, and ovarian) compared to normal tissues. Using machine-learning techniques, we further defined specific subsets of APA events to efficiently classify cancer types. Furthermore, APA patterns were associated with altered protein levels in patients, revealed by antibody-based profiling data, suggesting functional significance. Overall, our study offers a computational approach for use of APA in novel gene discovery and classification in common tumor types, with important implications in basic research, biomarker discovery, and precision medicine approaches.

[1]  Bin Tian,et al.  3′READS+, a sensitive and accurate method for 3′ end sequencing of polyadenylated RNA , 2016, RNA.

[2]  Mark A. Hall,et al.  Correlation-based Feature Selection for Machine Learning , 2003 .

[3]  A. Krogh,et al.  Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells* , 2008, Journal of Biological Chemistry.

[4]  A. Pasquinelli,et al.  MicroRNA silencing through RISC recruitment of eIF6 , 2007, Nature.

[5]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[6]  Ran Elkon,et al.  3’UTR Shortening Potentiates MicroRNA-Based Repression of Pro-differentiation Genes in Proliferating Human Cells , 2016, PLoS genetics.

[7]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[8]  A. E. Erson-Bensan,et al.  Alternative Polyadenylation: Another Foe in Cancer , 2016, Molecular Cancer Research.

[9]  A. E. Erson-Bensan.  Alternative polyadenylation and RNA-binding proteins. , 2016, Journal of molecular endocrinology.

[10]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[11]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[12]  Michael Recce,et al.  PolyA_DB: a database for mammalian mRNA polyadenylation , 2004, Nucleic Acids Res..

[13]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[14]  B. Tian,et al.  Alternative polyadenylation of mRNA precursors , 2016, Nature Reviews Molecular Cell Biology.

[15]  Mark A. Hall,et al.  Correlation-based Feature Selection for Discrete and Numeric Class Machine Learning , 1999, ICML.

[16]  Shiuan Chen,et al.  A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC–Grb2 interaction , 2004, Oncogene.

[17]  D. Bartel,et al.  Extensive alternative polyadenylation during zebrafish development , 2012, Genome research.

[18]  D. Banerjee,et al.  MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics , 2008, Cell cycle.

[19]  R. Urtasun,et al.  Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression , 2016, Oncogene.

[20]  F. Slack,et al.  A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. , 2008, Cancer research.

[21]  F. Bertucci,et al.  Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer , 2005, Molecular Cancer Research.

[22]  Sanghyuk Lee,et al.  MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.

[23]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  O. Kovalchuk,et al.  Estrogen-Induced Rat Breast Carcinogenesis is Characterized by Alterations in DNA Methylation, Histone Modifications, and Aberrant microRNA Expression , 2007, Cell cycle.

[25]  L. Staudt,et al.  The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.

[26]  Christine Mayr,et al.  Alternative 3'UTRs act as scaffolds to regulate membrane protein localization , 2015, Nature.

[27]  I. Jolliffe.  Principal Component Analysis , 2002 .

[28]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[29]  E. Lai,et al.  Widespread and extensive lengthening of 3′ UTRs in the mammalian brain , 2013, Genome research.

[30]  Wei Li,et al.  Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types , 2014, Nature Communications.

[31]  C. Mayr,et al.  Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.

[32]  T. Babak,et al.  A quantitative atlas of polyadenylation in five mammals , 2012, Genome research.

[33]  Tolga Can,et al.  Estrogen-induced upregulation and 3′-UTR shortening of CDC6 , 2012, Nucleic acids research.